Provided by:
CCEB Epidemiology Seminar Series
Academic Year 2014-2015
“Enhancing Comparative Effectiveness Research through Data Linkages: Examples from
Rheumatology”
November 6, 2014
9:00 AM- 10:00 AM
Class of 62 Auditorium, John Morgan Building
Jeffrey Curtis, MD, MS, MPH
Associate Professor of Medicine
Division of Clinical Immunology and Rheumatology
University of Alabama at Birmingham, AL
Target Audience
This program has been designed for departmental/institutional faculty, fellows, residents, medical students, other
health science students, nurses, allied health professional, and community physicians in the medical specialties of
internal medicine, infectious disease, gastroenterology, cardiology, endocrinology, obstetrics and gynecology,
nephrology, community health and prevention, oncology, critical care, pulmonary medicine, and cancer epidemiology.
psychiatry, allergy, emergency medicine, biobehavioral and health sciences, diabetes, rheumatology, geriatric medicine,
pediatrics, and pharmaeconomics.
Educational Objectives
After completing this activity, participants should be able to:
 Better interpret results of epidemiological studies in determining practice patterns bias
 Implement strategies learned to improve patient adherence to therapy
 Use new diagnostic and therapeutic techniques and treatments in their practice setting
Accreditation
The Perelman School of Medicine at the University of Pennsylvania is accredited by the Accreditation Council for
Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation of Credit
The Perelman School of Medicine at the University of Pennsylvania designates this live activity for a maximum of 1 AMA
PRA Category 1 Credit ™. Physicians should claim only the credit commensurate with the extent of their participation in
the activity.
Acknowledgement of Commercial Support*
NONE
For more information, please contact
Cathy Mulvaney
215-573-4866
cmulvane@mail.med.upenn.edu
Check your CME online at www.penncmeonline.com
Disclosure of Relevant Financial Relationships and Unapproved Uses of Products
It is policy at the Perelman School of Medicine at the University of Pennsylvania for individuals who are in a position to control
the content of an educational activity to disclose to the learners all relevant financial relationships that they have with any
commercial interest that provides products or services that may be relevant to the content of this continuing medical
education activity. For this purpose we consider relationships of the person involved in the CME activity to include financial
relationships of a spouse or partner.
The intent of this policy is not to prevent expert faculty with relevant relationship(s) with commercial interest(s) from
involvement in CME, but rather to ensure that Penn CME-certified activities promote quality and safety, are effective in
improving medical practice, are based on valid content, and are independent of control from commercial interests and free of
commercial bias. Peer review of all content was conducted for all faculty presentations whose disclosure information provided
to the Penn Office of CME was found to contain relationships that created a conflict of interest relative to the topic of their
presentation. In addition, all faculty were instructed to provide balanced, scientifically rigorous and evidence-based
presentations.
The staff in the Office of CME at the Perelman School of Medicine at the University of Pennsylvania, Mila Kostic, Director
of CME and the peer reviewer Zalman Agus, MD, Associate Dean for CME, have disclosed that they have no relevant
financial relationships with any commercial interests related to the content of this educational activity.
The following individuals have disclosed that they have no relevant financial relationships with any commercial interests
related to the content of this educational activity:
PLANNING COMMITTEE MEMBER NAME
DOUGLAS WIEBE, PHD
RUI FENG, PHD
STEVEN KAWUT, MD, MS
DAVID MARGOLIS, MD, PHD
PRESENTER NAME
JINBO CHEN, PHD
MARCELLA DEVOTO, PHD
BRIAN FINKELMAN
SCOTT HALPERN, MD, PHD, MBE
EBBING LAUTENBACH, MD, MPH, MSCEHONGZHE LI, PHD
MARY PUTT, PHD, SCH
KATHRYN SCHMITZ, PHD, MPH
The following individuals have reported the listed relevant financial relationships with commercial interests related to
the content of this educational activity.
PLANNING COMMITTEE MEMBER NAME
NAME OF COMMERCIAL INTEREST
RELATIONSHIP
ROBERT GROSS, MD, MSCE
JOHN KEMPEN, MD, PHD
MINGYAO LI PHD
PETER REESE, MD, MSCE
PRESENTER NAME
PFIZER
ALCON, ALLERGAN, CLEARSIDE, CAN-FITE, LUX BIOSCIENCES,
XOMA, SANOFI PASTEUR
GILEAD SCIENCES
ASTRA ZENECA, BRISTOL MYERS SQUIBB, MERCK
CVS CAREMARK
CONSULTANT
CONSULTANT
CONSULTANT
CONSULTANT
RESEARCH SUPPORT
IN KIND SUPPORT
NAME OF COMMERCIAL INTEREST
RELATIONSHIP
Jeffrey Curtis, MD, MS, MPH
Roche, Genentech, UCB
Consultant
Janssen, Corrone, Amgen
Consultant & Research
Abbvie, Pfizer, BMS
Consultant & Research
Crescendo
Relevant Financial Relationships: Financial relationships are those relationships in which the individual benefits by receiving a salary,
royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership
interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as
employment, management position, independent contractor (including contracted research), consulting, speaking and teaching,
membership on advisory committees or review panels, board membership, and other activities from which remuneration is received
or expected
DISCLOSURE OF UNAPPROVED USES OF PRODUCTS
PRESENTER NAME
PRODUCT
INVESTIGATIONAL AND/OR OFF-LABEL USE